You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

U2AF1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

Recruiting
  • Metastatic Solid Tumor
  • +4 more
  • Recommendation for treatment with immunotherapy
  • Baltimore, Maryland
    Johns Hopkins University
Sep 8, 2022

Patients With Atrial Fibrillation and Cancer

Active, not recruiting
  • Atrial Fibrillation
  • Cancer
    • Aalst, Belgium
    • +118 more
    Mar 15, 2022

    HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

    Recruiting
    • HIV-1-infection
    • INO-6160, 2 mg
    • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
    • New York, New York
    • +2 more
    Apr 13, 2023

    Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    Hiv Trial in Amsterdam (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage)

    Not yet recruiting
    • Hiv
    • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum) Dosage
    • Amsterdam, Netherlands
      The Amsterdam University Medical Centers
    Aug 2, 2023

    Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

    Recruiting
    • Locally Advanced Nasopharyngeal Carcinoma
    • 2 cycles induction chemotherapy
    • 3 cycles induction chemotherapy
    • Guangzhou, Other (Non U.s.), China
      First Affiliated Hospital, Sun Yat-Sen University
    May 6, 2023

    Long-Term Development of Muscular Dystrophy Outcome Assessments

    Not yet recruiting
    • LGMD1A
    • +33 more
      • Richmond, Virginia
        Virginia Commonwealth University
      Aug 3, 2023

      Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Graz, Austria
        Clinical Trials Unit, Medical University of Graz
      Mar 3, 2023

      Trastuzumab Emtansine in HER2-positive Breast Cancer Residual

      Recruiting
      • Breast Cancer
      • Trastuzumab emtansine
      • Prato, Firenze, Italy
      • +27 more
      Mar 2, 2023

      Hiv Trial (BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum))

      Not yet recruiting
      • Hiv
      • BG505 SOSIP.664 gp140 Vaccine, Adjuvanted (3M-052 AF plus alum)
      • (no location specified)
      May 8, 2023

      Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Nov 4, 2022

      Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

      Not yet recruiting
      • Acute Myeloid Leukemia With KMT2A Rearrangement
      • Acute Myeloid Leukemia With NPM1 Mutation
      • Biospecimen Collection
      • +7 more
      • (no location specified)
      Jun 1, 2023

      FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

      Active, not recruiting
      • FLT3 Gene Mutation Negative
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 16, 2022

      Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

      Not yet recruiting
      • Hiv
      • V3G CH848 Pr-NP1 60mcg
      • +5 more
      • Birmingham, Alabama
      • +5 more
      Jun 5, 2023

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • (no location specified)
      Jan 13, 2023

      T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

      Recruiting
      • T Acute Lymphoblastic Leukemia
      • T Lymphoblastic Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 11, 2023

      Type1 Diabetes Trial in Neuss (Insulin glulisine (U300), Insulin glulisine, Insulin aspart)

      Completed
      • Type1 Diabetes Mellitus
      • Insulin glulisine (U300)
      • +6 more
      • Neuss, Germany
        Investigational Site Number 276001
      Apr 21, 2022

      B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • Biospecimen Collection
      • +19 more
      • (no location specified)
      Nov 8, 2023

      Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myeloid Neoplasm
      • Biospecimen Collection
      • +9 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Sep 5, 2023

      Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

      Recruiting
      • Acute Myeloid Leukemia
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 7, 2022

      Solid Tumours in Advanced Stages Trial in Italy

      Recruiting
      • Solid Tumours in Advanced Stages
        • Ancona, Italy
        • +41 more
        Jun 15, 2023

        Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

        Active, not recruiting
        Has Results
        • Acute Myeloid Leukemia
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Oct 10, 2022

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +4 more
        • (no location specified)
        Nov 8, 2022

        Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

        Recruiting
        • Recurrent B Acute Lymphoblastic Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 2, 2022

        Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

        Recruiting
        • Acute Myeloid Leukemia
        • Biospecimen Collection
        • +5 more
        • Buffalo, New York
        • +1 more
        Jan 27, 2023